Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
-1.72%
)
Bitcoin
70,113.00
(
-0.57%
)
News Focus
News Focus
Post# of 257268
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: bladerunner1717 post# 105752

Wednesday, 10/06/2010 11:22:19 PM

Wednesday, October 06, 2010 11:22:19 PM

Post# of 257268

Why do you think a PI has to be part of the combo?

I didn’t say it did; rather, I said Roche evidently thinks a PI is needed and the rest of the industry (except VRUS) appears to agree.

What is wrong with a two-nuke/non-nuke combo or a two-nuke/NS5A inhibitor?

A 3-drug cocktail consisting of a nuke/nuke/NS5A or nuke/nuke/non-nuke might work; what I think is unlikely to work is VRUS’ idea of a 2-drug cocktail consisting of only nukes.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today